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Abstract: The increasing resistance of fungal pathogens has heightened the necessity of searching for
new organisms and compounds to combat their spread. Streptomyces are bacteria that are well-known
for the production of many antibiotics. To find novel antibiotic agents, researchers have turned to
previously neglected and extreme environments. Here, we isolated a new strain, Streptomyces sp. S-2,
for the first time, from black soot after hard coal combustion (collected from an in-use household
chimney). We examined its antifungal properties against plant pathogens and against fungi that
potentially pose threat to human health (Fusarium avenaceum, Aspergillus niger and the environmental
isolates Trichoderma citrinoviridae Cin-9, Nigrospora oryzae sp. roseF7, and Curvularia coatesieae sp.
junF9). Furthermore, we obtained the genome sequence of S-2 and examined its potential for
secondary metabolites production using anti-SMASH software. The S-2 strain shows activity against
all of the tested fungi. Genome mining elucidated a vast number of biosynthetic gene clusters (55),
which distinguish this strain from closely related strains. The majority of the predicted clusters were
assigned to non-ribosomal peptide synthetases or type 1 polyketide synthetases, groups known to
produce compounds with antimicrobial activity. A high number of the gene clusters showed no,
or low similarity to those in the database, raising the possibility that S-2 could be a producer of novel
antibiotics. Future studies on Streptomyces sp. S-2 will elucidate its full biotechnological potential.
Keywords: antifungal activity; biosynthetic gene clusters; black soot; coal-related environments;
genome mining; Streptomyces
1. Introduction
Streptomyces, a genus of Actinobacteria, includes over 800 species described so far [1]. These bacteria
are Gram-positive, have a large genome (8–10 Mbp) with high GC content, have a complex morphology,
and are widespread in soil, where they play important roles in the degradation of organic matter
and nutrient circulation (for a review, see [2]).
The members of this genus are known producers of a wide variety of secondary metabolites that
are important in medicine and industry [2–4]. Streptomyces are a major source for antibiotics used
by humans, as they produce over two-thirds of the clinically useful antibiotics that are of natural
origin [1,5–9]. Moreover, it has been estimated that Streptomyces potentially produce approximately
100,000 antimicrobial metabolites, of which only a small portion have been identified [5,7]. Furthermore,
they produce many other ecologically and biotechnologically important molecules such as pigments,
biologically active compounds, and exoenzymes [3,10,11]. In nature, microbial secondary metabolites are
an important part of ecological and physiological interactions with the environment and within microbial
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communities. They allow Streptomyces to outcompete other microorganisms as well as overcome
environmental stressors [12,13]—roles that are crucial especially in extreme environments [13–15].
Advancements in sequencing and genome mining methods have shown that Streptomyces have greater
than previously predicted potential to produce secondary metabolites, as a large number of biosynthetic
gene clusters (BGCs) have been revealed [5,16–19]. Often, more than 15% of the Streptomyces genome
is dedicated to secondary metabolism [20]. Most BGCs remain uncharacterized, and the peptides
that they encode may synthesize new antibiotics [17]. The expression of BGCs is tightly regulated,
and many remain in a dormant stage [2,4,18,19,21,22]. Recently, the activation of BGCs from Streptomyces
sclerotialus NRLP ISP-5269 using genetic engineering has led to the discovery of scleric acid, a new
compound that is active against Mycobacterium tuberculosis [23].
Extensive antibiotic resistance among bacteria and fungi is one of the major challenges in medicine
and agriculture. The need to constantly battle new pathogens has led to searches of previously neglected
and extreme environments for new strains that show antibiotic activity [1,13,24,25]. For instance,
several Streptomyces strains with antibiotic activity have been isolated from a marine sponge [26].
A thermotolerant strain showing antimicrobial potential, Streptomyces sp. TM32, has been recently
reported [17]. Furthermore, the novel alkaliphilic strain, Streptomyces sp. McG1, has been shown
to inhibit the growth of ESKAPE pathogens (Enterococcus feacium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumani, Pseudomonas aeruginosa, and Enterobacter spp.) [27]. Streptomyces
strains with antimicrobial activity have been found in insect microbiomes [25] as well as in Antarctica [13].
Many members of Streptomyces have antifungal properties [2,3,25,28–33]. Streptomyces varsoviensis
produces hygrobafilomycin, an antifungal macrolide with a unique molecular structure [34]. A new
species, Streptomyces fodineus, has shown antifungal activity against a broad range of filamentous
fungi. The strain was first isolated from acidic soil collected from an abandoned coal mine area in
Korea [1]. This points to mines and environments related to fossils as sources of new strains with
antibiotic activity.
A number of filamentous fungi are common pathogens of crops and other plants important
for agriculture and other industries [35–37]. Members of the genus Fusarium are examples of such
pathogens. Fusarium graminearum infects wheat, barley, and maize, causing losses for food and brewing
industries [38]. Another species, Fusarium oxysporum, is a pathogen with numerous potential hosts [36].
It causes Fusarium wilt of banana disease, one of the most destructive plant diseases of the modern
era [35]. Fusarium avenaceum, another pathogen with numerous hosts, can cause infections in crops,
peas, or other plants [39–41]. Nigrospora is another genus whose species are common pathogens of
plants [42–45]. Fighting fungal infections is thus of high importance. The use of synthetic fungicides
can place additional pressure on the environment, and their accumulation can cause unpredicted toxic
effects. Furthermore, their efficiency and the possibility of using them is influenced by seasonal weather
conditions. Therefore, researchers are trying to find natural biocontrol agents and natural antifungal
products [2,28,32,37]. The biological control of Fusarium wilt of banana has been investigated using both
bacteria and other fungi (for a review, see Reference [35]). Actinobacteria have also been studied for their
ability to protect plants from fungal infections [2,28,35,37,46,47]. One example is S. griseorubiginouse,
which has been shown to be effective against Fusarium wilt of banana [48]. However, this research
was limited to in vitro conditions and no field experiments were conducted [35]. S. lydicus WYEC 108
is part of a bio fungicide that has been approved by the Environmental Protection Agency (EPA) for
use in the United States (EPA registration number 73314-1) [49]. S. violaceusniger YCED9 produces
three antifungal compounds that are effective against plant pathogens [50]. Nevertheless, a continuous
search for new antibiotic-producing strains and new compounds with biological activity against plant
pathogens is important within the scope of constant development of resistance to existing agents.
Genome mining can be used to reveal gene clusters, leading to the synthesis of a large plethora of
new compounds and advancing the discovery of new antibiotics. Moreover, newly discovered strains
and compounds might be beneficial to the health of humans as well as to livestock and household animals.
A number of filamentous fungi pose a health hazard as they release mycotoxins that can cause severe
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diseases and death [32,51,52]. This group includes members of Aspergillus and Trichoderma, [32,51,53,54]
and the genus Fusarium, which can cause systemic infections [55]. New, natural fungicides can potentially
be of use for the reduction of exposure to mycotoxins, or could lead to new fungicides that can help
treat humans or animals.
The aim of this study was to examine the antifungal potential of a new strain, Streptomyces sp.
S-2, which was isolated from black soot after coal combustion (collected from a household chimney).
The influence of this strain on filamentous fungi, including plant pathogens, was investigated.
The genome of the new strain was sequenced and mined to elucidate the strain biosynthetic potential
of secondary metabolites. Streptomyces sp. S-2 exhibited strong antifungal activity against all tested
fungi. Genome mining revealed a large number of biosynthetic gene clusters suggesting that the strain
has the potential to produce novel compounds with biological activity.
2. Results
2.1. The Isolation of the Streptomyces sp. S-2 Strain From Black Soot
Here, 1 g of the black soot sample was spread onto a minimal salt medium (MSM) agar plate
supplemented with 1% hard coal dust (MSM-C2). After two weeks, a thin, white circlet appeared
around the piece of soot. This was collected and spread onto a fresh MSM-C2 agar plate. After 3 days,
colonies with a compact structure and creamy-white protrusions appeared, growing within the media.
Single colonies were spread onto nutrient agar (NA) and Mueller—Hinton agar (MHA) plates and were
used for Gram staining (Figure 1). On each medium, the colonies exhibited a typical Streptomyces
morphology that was compact and white on the MSM-C2 and slightly brown on the NA and MHA.
There were creamy-white protrusions on the MSM-C2 and creamy-white, wrinkled plaque on the NA
and MHA plates (Figure 1A). Gram staining showed Gram-positive bacteria with a mycelial-like
morphology (Figure 1B). Additionally, after 3 days, the colonies emitted an earthy/forest-like odor,
which is another distinct feature of Streptomyces. The strain also stained culture media releasing
a dark brown pigment. This occurred even when it was kept in pure culture. The strain was used for
further characterization.
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Figure 1. Morphology of Streptomyces sp. S-2 colonies. (a) Growth in solid cultures on 1% hard coal 
dust (MSM-C2), nutrient agar (NA), and Mueller—Hinton agar (MHA) plates. For the initial culture 
Streptomyces sp. S-2 was streak-inoculated on agar plates. The plates were incubated at 30 °C for 3 
days, after which pictures of the colonies were taken. The scale bar represents 5 mm (b) Bacterial 
mycelia stained using the Gram method. After 3 days, the colonies on the MSM-C2 agar plates were 
scraped using inoculation loop and suspended in 0.85% NaCl, dried, and stained using the Gram 
method, followed by observation with a light microscope under immersion, using a Plan-
ACHROMAT 100× 1.25NA objective (Carl Zeiss, Germany). Pictures were recorded using an 
AxioCam ERc 5s (Carl Zeiss, Germany). The scale bar represents 10 μm. All pictures were processed 
using Fiji software. 
2.2. Phenotypic Fingerprint of Streptomyces sp. S-2. 
Figure 1. Morphology of Streptomyces sp. S-2 colonies. (a) Growth in solid cultures on 1% hard coal
dust (MSM-C2), nutrient agar (NA), and Mueller—Hinton agar (MHA) plates. For the initial culture
Streptomyces sp. S-2 was streak-inoculated on agar plates. The plates were incubated at 30 ◦C for 3 days,
after which pictures of the colonies were taken. The scale bar represents 5 mm (b) Bacterial mycelia
stained using the Gram method. After 3 days, the colonies on the MSM-C2 agar plates were scraped
using inoculation loop and suspended in 0.85% NaCl, dried, and stained using the Gram method,
followed by observation with a light microscope under immersion, using a Plan-ACHROMAT 100×
1.25NA objective (Carl Zeiss, Germany). Pictures were recorded using an AxioCam ERc 5s (Carl Zeiss,
Germany). The scale bar represents 10 µm. All pictures were processed using Fiji software.
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2.2. Phenotypic Fingerprint of Streptomyces sp. S-2
To characterize Streptomyces sp. S-2, 8-day-old cell cultures were scraped from the MSM-C2 plates
and inoculated on GENIII microplate assay plates. The growth of the bacteria was measured 48 h
post-inoculation (Table 1 and Table S1). The strain is able to utilize 42 out of the 71 compounds in
the assay as a source of carbon and energy. These compounds included basic sugars, disaccharides
dextrins, and polyols (glycerol and D-mannitol). The strain is also capable of utilizing several amino
acids and a number of organic acids, including polycarboxylic acids. It has a proteolytic feature
(the utilization of gelatin) and the ability to degrade polysorbates (Tween 40). The Streptomyces sp. S-2
tolerates slight-to-moderate halophilic conditions (growth at an NaCl concentration of 1% to 8% with
a reverse correlation to salt concentration) and slightly acidic conditions (growth at pH 6 but not pH 5).
It is susceptible to all of the tested antibiotics except for nalidixic acid and Aztreonam. The strain is
able to grow in the presence of denaturing agents (guanidine HCl) and desiccants (lithium chloride),
features that could be connected to adaptation to extreme and arid environments, such as the black
soot from the household chimney.
2.3. Antifungal Activity of Streptomyces sp. S-2
The antifungal activity of Streptomyces sp. S-2 was tested against two fungi from culture
collections—Aspergillus niger and Fusarium avenaceum—and three fungi from the environment, including
two pathogens that were isolated from a garden rose and a juniper. Fungal strains isolated from
the environment were selected for the study based on their different morphologies in order to obtain
diverse genera. The selected fungi were identified by sequencing the internal transcribe spacer (ITS)
region and searching the National Center for Biotechnology Information NCBI database using a Blast
tool. All sequences were deposited in the NCBI database. The fungi used in the study were from
a cinder sample: Trichoderma citrinoviridae Cin-9 (MN756678), from a garden rose: Nigrospora oryzae
roseF7 (MN756677), and from a juniper: Curvularia coatesieae junF9 (MN756676).
To test the antifungal activity, the S-2 strain was simultaneously co-cultured with fungi on MHA
or NA plates. The plates were cultured at 25 ◦C, a temperature optimal for fungi growth, except for
co-cultures with T. citrinoviridae Cin-9, which were cultured at 30 ◦C. Fungi growth was investigated
every day for 14 days. Representative pictures of the co-cultures are shown in Figure 2. Antifungal
activity was measured by comparing the inhibition of mycelial growth towards the center of the S-2
colonies to growth towards the border of the plates. The S-2 strain exhibited antifungal activity against
all of the tested fungi, but at different levels of inhibition (Figure 3; data not shown). The effect
was visible early in the co-cultures with the fast-growing fungi (T. citrinoviridae Cin-9 and N. oryzae
roseF7). The highest antifungal activity was observed against N. oryzae roseF7, where, over time,
a visual inspection of plates indicated that compactness of the mycelium decreased (data not shown),
suggesting lysis of the fungi. A strong inhibitory effect was also observed for C. coatesieae junF9.
A moderate effect was observed for F. avenaceum. For T. citrinoviridae Cin-9 and A. niger, even though
there was a high level of inhibition observed at the beginning of the co-culture, during the course of
the experiment, both fungi were able to nearly completely cover the plates with mycelia (Figure 2).
Importantly, when the fungal mycelia reached the S-2 colonies, further growth could not be measured
even though the fungi could have been viable. Thus, this was a situation in which measuring growth
distances did not reflect actual effects. Therefore, to better compare the effects of S-2 on the tested
fungi, the relative growth inhibition was measured on the day when the mycelia that were growing
towards the plate border reached a distance of S-2 inoculation spots, 20 mm from the plate center
(Figure 3). For N. oryzae roseF7 and T. citrinoviridae Cin-9 this was on day 2 post-inoculation, for A.
niger and F. avenaceum this occurred on day 4 post-inoculation, and for C. coatesieae junF9 this was on
day 5 post-inoculation. At the point when the mycelia reached that distance, the strongest inhibitory
effect was observed against T. citrinoviridae Cin-9 (53.84% ± 7.17%; n = 15), followed by C. coatesieae
junF9 (45.97% ± 4.67%; n = 18), then F. avenaceum (40.81% ± 5.97%; n = 15), and A. niger (39.86% ±
7.86%; n = 14), and finally N. oryzae roseF7 (35.54% ± 14.17%; n = 16) (Figure 3).
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Table 1. Streptomyces sp. S-2 phenotypic fingerprint based on a GEN III microplate assay after 48 h of incubation.
Carbon Source Assay
Compound OD590 Compound OD590 Compound OD590 Compound OD590
Saccharides
α-D-Glucose 0.214 ± 0.064 D-Galactose 0.089 ± 0.046 D-Mannose 0.120 ± 0.063 D-Fructose 0.196 ± 0.047
D-Cellobiose 0.145 ± 0.037 Gentiobiose 0.320 ± 0.151 D-Turanose 0.036 ± 0.026 N-Acetylo-D-Glucosamine 0.082 ± 0.44
Dextrin 0.155 ± 0.088
Saccharide derivatives
N-Acetyl-β-D-Mannosamine 0.077 ± 0.023 D-Glucose-6-Phosphate 0.086 ± 0.033 D-Fructose-6-Phosphate 0.063 ± 0.053 N-Acetyl- Neuraminic Acid 0.183 ± 0.021
Mucic Acid 0.065 ± 0.041
Glycosides and polyols
β-D-Methyl-D-Glucoside 0.098 ± 0.049 D-Salicin 0.175 ± 0.030 Glycerol 0.112 ± 0.048 D-Mannitol 0.067 ± 0.049
Organic Acids
Formic Acid 0.291 ± 0.082 Acetic Acid 0.249 ± 0.029 Propionic Acid 0.237 ± 0.021 Citric Acid 0.104 ± 0.076
L-Lactic Acid 0.315 ± 0.224 D-Gluconic Acid 0.595 ± 0.127 D-Malic Acid 0.133 ± 0.024 L-Malic Acid 0.420 ± 0.083
Acetoacetic Acid 0.114 ± 0.031 Bromo-Succinic Acid 0.193 ± 0.084 Methyl Pyruvate 0.218 ± 0.021 α-Hydroxy-Butiric Acid 0.318 ± 0.082
β-Hydroxy-D,L-Butyric Acid 0.267 ± 0.024 α-Keto-Butyric Acid 0.248 ± 0.042 γ-Amino-Butyric Acid 0.102 ± 0.003 D-Lactic Acid Methyl Ester 0.176 ± 0.041
Amino Acids
L-Alanine 0.115 ± 0.087 L-Histidine 0.199 ± 0.047 L-Aspartic Acid 0.134 ± 0.098 L-Glutamic Acid 0.125 ± 0.069
Glycyl-L-Proline 0.095 ± 0.020
Others
Gelatin 0.220 ± 0.009 Inosine 0.102 ± 0.026 Tween 40 0.266 ± 0.102
CHEMICAL SENSITIVITY ASSAY
pH 6 0.487 ± 0.107 1% NaCl 1.018 ± 0.294 4% NaCl 0.636 ± 0.151 8% NaCl 0.349 ± 0.103
1% Sodium Lactate 0.508 ± 0.146 Guanidine HCl 0.364 ± 0.039 Nalidixic Acid 0.456 ± 0.107 Aztreonam 0.250 ± 0.085
Sodium Butyrate 0.467 ± 0.160
The values represent bacterial growth measured as optical density (OD) at a 590 nm wavelength. The values are the mean and standard deviation error calculated from three individual
biological repeats.
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Figure 2. The inhibition of fungal growth by Streptomyces sp. S-2. Representative pictures of the S-2
strain and each fungus co-culture showing the inhibition of fungal mycelia growth taken at 3rd, 5th,
and 14th day of the cultures. For each co-culture, MHA plates were used except for the co-culture with
Trichoderma citroviridae Cin-9, which was performed on NA plates. The S-2 strain was spot-inoculated
at the 20 mm distance from the center of plate, followed by placing a puck of agar with fungal mycelium
at the center of the plate. Plates were incubated at 25 ◦C, except for the co-culture with T. citrinoviridae
Cin-9, which was incubated at 30 ◦C. Co-cultures were investigated daily and pictures of the co-cultures
were taken. For each co-culture, at least 14 plates were analyzed.
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Figure 3. Inhibition of fungal growth by Streptomyces sp. S-2. Charts comparing the growth of fungal
mycelia towards the plate border (WALL) or toward the S-2 strain colonies (S-2) on co-culture plates
and fungal mycelia growth toward the border of the plates on control plates (CTRL). For each co-culture,
MHA plates were used except for the co-culture with T. citroviridae Cin-9 which was performed on
NA plates. The S-2 strain was spot-inoculated at a distance 20 mm from the center of the plate,
followed by the placement of a puck of agar with fungal mycelia at the center of the plate. Plates were
incubated at 25 ◦C, except for the co-culture with T. citrinoviridae Cin-9 which was incubated at 30 ◦C.
For each co-culture, at least 14 plates were analyzed. Three control plates for fungal growth control for
each experimental set were also analyzed. A growth comparison for each fungus on the day when
fungal mycelia grew ≥ 20 mm (the distance at which the S-2 strain was inoculated) is indicated in
brackets above the charts. Statistically significant inhibitions of growth are represented by an asterisk
(*) (one-way ANOVA followed by Tukey’s post hoc test, p ≤ 0.05).
To further investigate antifungal activity and overc me th issues with the co-cultures that
were mentioned above, Streptomyces sp. S-2 was inoculated in the same way as before, but with
pre-incubation for 3, 7, and 14 days. Next, a agar puck with mycelia was placed at the center
of the plates and incubated for an additional 7 days. After that, fungal growth was classified
as “-” (no growth), “+” (growth up to 7 mm), “++” (growth between 7 and 15 mm), or “+++”
(growth above 15 mm) (Table 2). On the plates pre-incubated for 3 days, all fungi were able to grow,
with T. citrinoviridae Cin-9 showing the fastest growth. However, growth was diminished co pared to
plates with simultaneous co-cultures. On the plates pre-incubated for 7 days, N. oryzae roseF7 was not
able to grow, and the growth of the other fungi was reduced. Finally, on the plates pre-incubated for
14 days, none of the fungi used in the test were able to grow (Table 2). This experiment confirmed
the antifungal activity of Streptomyces sp. S-2 against a variety of fungi. Further, it indicated that one or
more products secreted by bacteria in the late phase of growth were responsible for the antifungal
activity observed.
2.4. Genome Sequencing and Phylogeny of Streptomyces sp. S-2
Whole-genome sequencing of Streptomyces sp. S-2 was performed using the Illumina MiSeq
platform. The assembled sequence was deposited in GenBank under accession no. WMKI00000000.
The total assembled genome of strain S-2 was 6.97 Mbp with a GC content of 73.1% and 6680 CDS.
Statistical data for the genome sequence are presented in Table 3. A maximum-likelihood phylogenetic
analysis was performed using the core proteomes of 18 Streptomyces strains. It showed the closest
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relation of the S-2 strain to be S. albus J1074 (Figure 4). Therefore, we suggest that the isolate is a new
strain of the Streptomyces genus and is closely related to S. albus.
Table 2. Inhibition of fungal growth on plates with pre-cultured Streptomyces sp. S-2.
Fungus species pre-cultured Streptomyces sp. S-2
3 days 7 days 14 days
Fusarium avenaceum ++ + -
Aspergillus niger ++ + -
Trichoderma citrinoviridae Cin-9 +++ ++ -
Nigrospora oryzae RoseF7 ++ - -
Curvularia coatesieae JunF9 ++ + -
An agar puck with mycelia was placed in the middle of plates with three colonies of Streptomyces sp. S-2. The plates
were incubated for 7 days, and the growth of the fungi was measured as the radius between the puck and center
of the S-2 colony: “-” (no growth), “+” (growth up to 7 mm), “++” (growth between 7 and 15 mm), and “+++”
(growth above 15 mm).
Table 3. Next Generation Sequencing (NGS) statistical data based on a draft genome of S-2.
Streptomyces sp. S-2 Draft Genome
Number of contigs 1799
Contigs sum (bp) 6.971375
N50 6745
Longest contig (bp) 62.211
Shortest contig (bp) 407
Average length (bp) 3875
% GC content 73.1
Number of CDS 6680
2.5. Prediction of Secondary Metabolites Biosynthetic Gene Clusters (BGCs) in the Streptomyces sp.
S-2 Genome
The Streptomyces sp. S-2 genome was subjected to a prediction of secondary metabolites
biosynthetic gene clusters using the anti-SMASH database. The prediction revealed that the genome
encompasses a total number of 55 BGCs. Moreover, 32 of the predicted BGCs show no similarity to any
of the clusters in the database (as of December 2019). Multiple clusters encode non-ribosomal peptide
synthetases (NRPS) (21 clusters) and NRPS-like clusters (3); type I polyketide synthases (T1PKS)
(11 clusters); type II polyketide synthases (T2PKS) (1 cluster); type III polyketide synthases (T3PKS)
(1 cluster); bacteriocins (2 clusters); lanthipeptides (1 cluster); and clusters with a hybrid character (3).
All of these cluster types are known to encode genes responsible for the production of compounds
with biological activity, including antibiotics. Among these groups, the BGCs with no similarity to
known biosynthetic clusters included 17 NRPS and NRPS-like clusters, 8 T1PKS clusters, 2 bacteriocins
clusters, and 1 lanthipeptide cluster. This means that there is a heightened chance that Streptomyces sp.
S-2 is able to produce novel antibiotics. Among the other types of BGCs with no similarity to known
products were the 2 siderophores and 2 terpenes. A detailed analysis of the anti-SMASH results,
which are reported in Table 5, showed the presence of BGCs typical for the Streptomyces genus: those
used for the synthesis of geosmin, a compound responsible for the earthy odor, and desferrioxamine B,
a siderophore involved in iron chelation. A BGC similar to that used for the synthesis of osmolyte
ectoine (75% similarity) is present, which is not surprising given the arid environment of the chimney’s
black soot. There is also a number of BGCs with moderate-to-low similarity to those that encode
antibiotics, fungicides, and other bioactive substances (Table 5).
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Figure 4. Maximum-likelihood phylogenetic tree of the Streptomyces sp. S-2 strain. The tree
shows the phylogenetic relationships between the S-2 strain and closely related Streptomyces strains.
The phylogenetic tree was inferred using IQ-TREE Galaxy software from an alignment of the core
proteomes of 19 Streptomyces strains. The numbers at the nodes represent bootstrap values (% of 1000
repeats). The position of Streptomyces sp. S-2 strain has been highlighted in red for better visibility.
Table 4. The distribution of BGCs from Streptomyces sp. S-2.
Gene Type Span [nt] Most Similar Biosynthetic Gene Cluster
From To
Bacteriocin 1 8813 -
Bacteriocin 1 1875 -
Ectoine 1 4689 Ectoine (75%)
Lanthipeptide 1 6359 -
NRPS 1 14,680 -
NRPS 1 7664 -
NRPS 1 7000 -
NRPS 1 5847 -
NRPS 1 3863 -
NRPS 1 3784 -
NRPS 1 3409 -
NRPS 1 3289 -
NRPS 1 3179 -
NRPS 1 3061 -
NRPS 1 2796 -
NRPS 1 2701 -
NRPS 1 2511 -
NRPS 1 1858 -
NRPS 8528 41,043 Diisonitrile entibiotic SF2768 (66%)
NRPS 1 20,858 Mannopetimycin (37%)
NRPS 1 27,653 Surugamide A / Surugamide D (19%)
NRPS 1 6554 Curacomycin (18%)
NRPS 1 30,250 Dechlorocuracomycin (16%)
NRPS 1 7538 Desotamide (9%)
NRPS 1 10,029 Mannopeptimycin (7%)
NRPS-like 1 7313 -
NRPS-like 1 4785 -
NRPS-like 1 1417 -
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Table 5. The distribution of BGCs from Streptomyces sp. S-2.
Gene Type Span [nt] Most Similar Biosynthetic Gene Cluster
From To
Hybrid
(NRPS-like, T1PKS) 1 22,016
Levorin A3/C06690/FR-008-III/candicidin
A/UNII-AP5PEF5W7U (66%)
siderophore 4004 10,744 -
siderophore 1 1673 -
siderophore 1 10,733 Desferrioxamine B (100%)
T1PKS 1 18,159 -
T1PKS 1 6047 -
T1PKS 1 6025 -
T1PKS 1 5494 -
T1PKS 1 4600 -
T1PKS 1 3778 -
T1PKS 1 1980 -
T1PKS 1 1646 -
T1PKS 1 15,272 ECO-02301 (32%)
T1PKS 1 14,101 Candicidin (23%)
T1PKS 1 16,488 Reedsmycins (20%)
Hybrid
(T1PKS, NRPS) 1 13,542 Antimycin (20%)
Hybrid
(T1PKS, NRPS) 1 13,498 Antimycin (13%)
T2PKS 1 16,805 Fredericamycin A (45%)
T3PKS 1 8472 Herboxidiene (7%)
Terpene 1 4631 -
Terpene 1 4141 -
Terpene 1 2347 Geosmin (100%)
Terpene 1 9567 Hopene (53%)
Terpene 1 6983 Isorenieratene (25%)
Terpene 1 1604 Hopene (15%)
Terpene 1 1104 Hopene (15%)
Terpene 3697 13,999 Phoshonoglycans (6%)
Biosynthetic gene clusters (BGCs) predicted based on the anti-SMASH database (% indicates the proportion of
genes with similarities). TIPKS: type I polyketide synthase; TIIPKS: type II polyketide synthase; TIIIPKS: type III
polyketide synthase; NRPS: non-ribosomal peptide synthase.
The number of BGCs from Streptomyces sp. S-2 was compared to the number of BGCs from other
members of the genus (Figure 5 and Table S2). The comparison showed that Streptomyces sp. S-2
excels in terms of the number of BGCs. What is worth noticing, is that the genome of strain S-2 is
enriched in NRPS and T1PKS clusters in comparison to other Streptomyces, especially phylogenetically
close companions. At the same time, only three clusters have low similarity to the hopene synthesis
pathway, the compound that might play a role in adaptation to environments with high temperatures.
Interestingly, the number of BGCs in the S-2 genome exceeds more than twice the number of BGCs
identified in its close relatives, S. albus J1074 (22) and S. albus SM254 (21) (Figure 5). This number is
also higher by more than 20 than the number of BGCs in S. wadayamensis A23 (36), another closely
related Streptomyces strain.
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and strains with a high number of BGCs reported in the literature. The BGCs in each genome were
predicted using the anti-SMASH database. The “Hybrid” type clusters that were predicted to belong to
more than one type of BGC were pooled. The BGCs that were predicted to belong to the siderophore,
ectoine, thiopeptide, indole, melanin, or linardin types which were pooled in “Other”. The position of
Streptomyces sp. S-2 has been highlighted in red for better visibility.
3. Discussion
We isolated a new Streptomyces sp. S-2 strain from black soot after the combustion of hard coal.
The black soot sample was collected from an in-use household chimney. To our knowledge, this is
t e first case of a microorganism being isolated from black soot. Phenotype fingerprinting using
a GEN III microplate assay revealed that the S-2 strain can use a variety of compounds as a source
of carbon and energy. This is not surprising, as high metabolic potential is a characteristic feature of
the Streptomyces genus [2]. The assay also showed that S-2 is moderately halotolerant (with the ability to
grow at 8% NaCl concentration) and can grow in the presence of desiccants. This suggests t e strain has
the ability to be viable i environments with low water potential, such as in chimney soot. A number
of ot er halophilic or halotolerant Streptomyces strains have been previously isolated, and clearly
this feature depends on environmental conditions [26,56,57]. The S-2 strain shows strong antifungal
activity against plant pathogens and filamentous fungi potentially dangerous to huma s. We observed
the inhibition of fun al growth by S-2 early in the si ultaneous co-culture with tested f ngi, although
with different levels for different fun al genera. Notably, Streptomyces produce antibiotics mainly
in the later phase of growth, when the sporulation process takes place [58,59]. M reover, both T.
citrinoviridae Cin-9 and A. niger may respond to S-2 secondary metabolites through the secretion of
enzymes whic counteract the inhibitory effect of compounds found in the environment. Members of
t e Trichoderma genus are also used as biocontrol agents, and as such have anti icrobial activity a d are
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resistant to a plethora of adverse compounds [60–62]. In our experiment, both bacteria and fungi
were inoculated simultaneously. This could have potentially influenced the degree of the observed
inhibitory effect, especially in the case of fast-growing fungi (i.e. members of the Trichoderma, Aspergillus,
or Nigrospora genera). Nevertheless, significant inhibition on day 2 of the co-culture indicated that
Streptomyces sp. S-2 has strong antifungal properties. In co-cultures with pre-cultured S-2, the effect was
even more pronounced, resulting in the complete inhibition of fungal growth on plates with bacteria
pre-cultured for 7 and 14 days for N. oryzae roseF7 and for all tested fungi, respectively. Recently, there
have been a number of reports of new Streptomyces strains isolated from extreme and non-conventional
environments that are showing antimicrobial activity [1,13,24,25]. Streptomyces strains have also been
previously studied for their potential to protect plants against fungal infections [2,35]. One example
is S. lydicus WYEC 108, a bioactive compound in antifungal product sold in the United States, for
agricultural use [49]. Another example is S. violaceusniger YCED9, which produces antifungal agents
able to combat various plant pathogens, including members of Fusarium, Phythium, and Phytophthora
genera [50]. On the other hand, field trials to use Streptomyces strains as a biocontrol agent in banana
wilt disease are have not yet been reported [35].
Sequencing has shown that the size of the S-2 genome (<7 Mbp) as well as number of coding
sequences (CDS) (<7000) are on the lower end for Streptomyces genus whose members’ genomes are
8.6 Mbp on average and contain more than 7000 CDS [5,13]. At the same time, the genome mining
of S-2 revealed 55 BGCs. A higher-than-average number of BGCs (20-30) that has been reported for
mesophilic Streptomyces [13,63]. It is also more BGCs than identified in Streptomyces isolated from
extreme environments, like Artic soil, caves or coal mine soil [1,13,24]. Interestingly, the number of
BGCs in the S-2 genome exceeds those identified in genomes of closely related strains. Recent work by
Chevrette et al. [25] has shown that the ecology of a microorganism influences its metabolic potential.
This could be the explanation for the high number of BGCs in the S-2 genome, giving the strain
an advantage in the competition for scarce nutrients in a black soot environment. Similarly, two
strains of Streptomyces sp. ICC1 and ICC4, isolated from the Iron Curtains Cave have been reported
to have a higher number of BGCs than their closest terrestrial counterpart, S. lavendulae, has [24].
To the best of our knowledge, only two strains with a higher number of BGCs than S-2 have been
described: S. griseochromogenes ATCC-14511 [13] and Streptomyces sp. GMR22 [64], with 59 and 63
BGCs respectively. However, those analyses were performed with an older version of the anti-SMASH
database. A re-analysis with anti-SMASH version 5.1.0 revealed the presence of a lower number
of BGCs in S. griseochromogenes ATCC-14511 than before, 47 versus 59. Due to not being able to
access the genome of Streptomyces sp. GMR22, we were unable to assess the number of BGCs in
this strain. Moreover, in our study, 32 out of 55 identified BGCs were classified as either NRPS
(21 clusters) or T1PKS (11 clusters). Both groups of BGCs are known to encode proteins involved
in biosynthesis and the processing of secondary metabolites with various antibiotic activities [65].
In other microorganisms, NRPS are responsible for synthesis of compounds such as actinomycin,
vancomycin, and coelibactin [66–68], and T1PKS produce compounds such as rapamycin, cyphomycin,
and glutaramides [18,25,69]. On the other hand, phenotype fingerprinting using a microplate assay
showed that the S-2 strain was susceptible to several antibacterial antibiotics targeting protein synthesis.
Streptomyces sp. myrophorea McG1, which has antibacterial activity, has been shown to be resistant
to a number of antibiotics, including those targeting protein synthesis [27]. This might suggest
a lack of antibacterial activity in Streptomyces sp. S-2. However, in that study, the resistance to some
antibiotics of the McG1 strain was established after 6 days of culture, and the test was performed using
different methodology [27]. The high number of BGCs, as well as the prevalence of NRPS and T1PKS
clusters, distinguish the S-2 strain from other Streptomyces strains, especially considering its relatively
small genome size. Finally, 32 of the identified BGCs show no similarity to any clusters present in
the database, and 10 show only low similarity (below 20%). This seems particularly interesting, as it
may lead to the production of novel compounds. The same has been suggested for BGCs with low
overall similarities to known compounds in other Streptomyces [24].
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The results reported in this study point to the capability of Streptomyces sp. S-2 to produce
a large number of secondary metabolites. The high numbers of clusters in the NRPS and T1PKS
groups indicate that many of its produced metabolites may have antibiotic activity. A number
of them might be novel compounds and may be beneficial in medicine and industry. Secondary
metabolites produced by Streptomyces sp. S-2, aside from antibiotic activity, might display antitumor,
anti-inflammatory, or antioxidant activities, or function as insecticides. Such activities have been
previously reported in the Streptomyces genus [2,10,70–72]. Considering the biosynthetic potential of
the S-2 strain, future research focusing on investigation of these activities is ensured.
It should be noted that some biosynthetic clusters might be dormant and might only be expressed
under specific conditions or upon activation by external factors. In members of Streptomyces, it has been
shown that a co-culture with other microorganisms might stimulate the production of antibiotics [22].
A two-component signaling cascade is known to be present in these bacteria and might induce
the expression of secondary metabolites under specific environmental conditions, e.g. nutrient
deprivation [21]. Additionally, the activation of dormant BGCs through genetic manipulation resulting
in the production of a new antimicrobial compound has recently been reported [23]. The results from
co-cultures with pre-cultured S-2 suggest a constitutive production of antifungal agents by the strain.
Nevertheless, a detailed examination of BGCs expression and the activities of the compounds produced
by S-2 should be the focus of future research, as this could elucidate the full biotechnological potential
of the strain.
4. Materials and Methods
4.1. Microbial Culture Media
Minimal salt medium (MSM) was prepared according to Malik et al. [73] to isolate
the microorganisms from the black soot and cinder samples. For media supplementation, hard coal dust
was obtained by grinding hard coal pieces using a ball mill. For media solidification ultra-pure agar
was added for a final concentration of 1.5% (Select Agar, ThermoFisher Scientific, Waltham, MA, USA).
For the fungal cultures potato dextrose agar (PDA) medium was used. For antifungal activity, nutrient
agar (NA) and Mueller—Hinton agar (MHA) media were used. For the selection of transformants
Luria–Bertani (LB) medium supplemented with 1.5% agar, 50 µg/mL ampicillin (Sigma-Aldrich,
Darmstadt, Germany), 40 µg/mL X-gal and 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was
used (both from A&A Biotechnology, Gdynia, Poland). For liquid cultures, nutrient broth (NB) and LB
media were used for S-2 and transformed E. coli DH5α, respectively. All media were purchased from
BTL sp. z o.o., Łódz´, Poland, unless stated otherwise.
4.2. Sampling and Strains Isolation
The black soot sample was collected from a household chimney under active use (50.191846
N, 19.108628 E) on 19 December 2017 in the city of Mysłowice, Poland. At the time of collection,
the chimney interior had a temperature of 30 ◦C and was exhausting smoke from hard coal combustion.
The soot sample was scraped off the chimney wall with a sterilized spoon into a sterile 50 mL tube
and transferred to the laboratory. A sample of cinder after hard coal combustion was collected from
under the household’s hearth on the same day and in the same location as the black soot sample. The top
layer of cinder was scraped off the pile, and the exposed cinder was collected into a sterile 50 mL tube
with a sterilized spoon and transferred to the laboratory. 1 g of each sample was spread onto an MSM
agar plate supplemented with 1% (w/v) hard coal dust. Plates were incubated at 30 ◦C. After 2 weeks,
the plates were investigated, and bacterial and fungal strains were passed onto MSM agar plates
supplemented with 2% (MSM-C2) hard coal dust, in order to isolate pure cultures. Strains S-2 from
the black-soot-inoculated plate and Cin-9 from the cinder-inoculated-plate were chosen for subsequent
experiments. S-2 resembled the morphology of Actinobacteria, and Cin-9 resembled the morphology
of Trichoderma.
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The microscopic morphology of isolated bacteria was investigated by using Gram staining.
A colony was suspended in a drop of 0.85% NaCl and smeared on a microscope slide, air-dried,
and heat fixed. Then, the specimen was stained through flooding, as follows: crystal violet for 3 min,
Gram’s iodine for 2 min, 20% ethanol for 30 s, and carbol fuchsin for 30 s, followed by air-drying.
A microscopic observation of the specimen was performed using a PrimoStar microscope (Carl Zeiss,
Jena, Germany) with a Primo Plan-ACHROMAT 100x NA1.25 objective (Carl Zeiss, Jena, Germany)
under immersion. Pictures were recorded using an AxioCam ERc 5s (Carl Zeiss, Jena, Germany)
and processed using Fiji software, (version 1.52p) [74]
On 18 August 2018, garden rose leaves showing signs of fungal infection were collected into
a sterile 50 mL tube and transferred to the laboratory to isolate fungi. The leaves were surface sterilized
in a microbiological flow cabinet by washing them in 70% ethanol, followed by washing them in
5% commercial bleach solution (ACE, Procter & Gamble, Cincinnati, OH, USA) and then washing
them twice in deionized water. Next, the leaves were placed on PDA plates and incubated at 22 ◦C.
After 7 days of incubation, the colonies growing from the leaves were placed on fresh PDA plates
and incubated at 22 ◦C in order to isolate the pure cultures. The strain isolate N. oryzae roseF7 was
used for subsequent experiments.
Juniper branches with “slime mold” were collected into a sterile 50 mL tube and transferred to
the laboratory. Pieces of branches with “slime mold” were placed on PDA plates in a microbiological
flow cabinet and incubated at 22 ◦C. After 7 days of incubation, the colonies growing from the inoculated
material were placed onto fresh PDA plates incubated at 22 ◦C in order to isolate the pure cultures.
The C. coatesieae junF9 strain was used for subsequent experiments.
4.3. Microorganism Strains
The Aspergillus niger used in this study was obtained from the Institute of Biology, Biotechnology
and Environmental Protection, University of Silesia in Katowice. The Fusarium avenaceum strain isolated
from the environmental sample was obtained from the Institute of Biotechnology for Agriculture-Food
Industry, Poland. For the transformation with ITS, amplicon Escherichia coli DH5α strain was used.
4.4. DNA Isolation and Sequencing
After 8 days of culture on the MSM-C2 agar plate, the S-2 strain was loop inoculated in 5 mL of
NB medium and incubated at 30 ◦C, with shaking at 120 rpm for 72 h. Next, the cells were pelleted
through centrifugation at 10,000 rcf and used for DNA extraction. Genomic DNA was extracted using
a PowerSoil DNeasy Kit (MoBio, Carlsbad, CA, USA) according to the manufacturer’s protocol, with
the exception that instead of soil, cell pellet was used as the sample. The integrity of the DNA was
examined by agarose gel electrophoresis. The whole genome sequencing was performed by MicrobesNG
(Birmingham, United Kingdom) using an Illumina MiSeq platform with 2 × 250-bp paired-end reads.
The results of the sequencing were put through a standard MicrobesNG analysis pipeline.
Isolated fungal strains were cultured on PDA plates at 22 ◦C for 8 days, except for the Cin-9
strain, which was cultured at 30 ◦C. Next, the mycelia were harvested and homogenized using a sterile
ceramic mortar and pestle. The homogenates were used for DNA extraction, which was performed
with a DNeasy PowerLyzer PowerSoil Kit (MoBio, Carlsbad, CA, USA) according to the manufacturer’s
protocol. For fungal strain identification, the ITS region was amplified using an ITS1F primer
(5’-TCCGTAGGTGAACCTGCGG-3’) and ITS4R primer (5’-TCCTCCGCTTATTGATATGC-3’). In each
sample, the reaction mix was composed of DreamTaq polymerase, 0.25 µL (1.25 U), 10x DreamTaq
buffer, 5 µL, dNTPs mix, 5 µL (2 mM of each dNTP), primers, 0.25 µL of each (0.5 µM each), template,
and nuclease-free water to fill to 50 µL. All reagents were purchased from Thermo Fisher, Waltham,
MA, USA, except for the primers, which were ordered from Sigma–Aldrich, Darmstadt, Germany.
Between 10 pg and 1 µg of fungal DNA was used as a template. PCR was performed as follows:
initial denaturation at 95 ◦C for 10 min, followed by 35 cycles of denaturation at 95 ◦C for 30 s,
primers annealing at 57 ◦C for 30 s, elongation at 72 ◦C for 1 min, and final elongation at 72 ◦C for
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15 min. PCR products were purified using a Clean Up Ax Kit (A&A Biotechnology, Gdynia, Poland).
Purified products were ligated into a pJET1.2 vector using a Clone JET PCR Cloning Kit (Thermo
Fisher, Waltham, MA, USA) and subsequently transformed into chemically competent E. coli DH5α.
Positive transformants were selected using a blue-white screen on LB plates supplemented with
ampicillin (50 µg/mL), X-gal (40 µg/mL), and IPTG (0.1 mM). Vectors from positive clones were isolated
using a GeneJet Plasmid MiniPrep Kit (Thermo Fisher Scientific, Waltham, MA, USA) according to
the manufacturer’s protocol. Insert sequencing was performed by Macrogen (Amsterdam, Netherlands)
using the Sanger method with a pJET1.2 forward primer (5′-CGACTCACTATAGGGAGAGCGGC-3′)
and a pJET1.2 reverse primer (5′-AAGAACATCGATTTTCCATGGCAG-3′). Fungal strains were
identified using by retrieving sequences of ITS1, 5.8S rRNA, ITS2, and partial large subunit rRNA
fragment of closely related strains using a Blast tool [75].
4.5. Phylogenetic Analysis of Streptomyces sp. S-2
The phylogenetic tree was created by extracting and aligning the core proteomes of the S-2 and 18
Streptomyces strains (list of strains available in Table S3) using M1CR0B1AL1Z3R [76]. Poorly aligned
regions were removed using Gblocks (version 0.91b) [77], which yielded 176,196 amino acids for 18
genomes. A maximum-likelihood phylogenetic tree was inferred using IQ-TREE Galaxy (version 1.5.5.3)
with default settings and 1000 bootstraps [78]. Finally, the phylogenetic tree was visualized using
the iTOL Interactive tree of life tool (version 5.5) [79], and is available at https://itol.embl.de/tree/
19348172168181091583040528.
4.6. Secondary Metabolite Gene Clusters Prediction
The prediction of biosynthetic gene clusters for secondary metabolite synthesis was performed
using Antibiotic and Secondary Metabolite Analysis Shell (anti-SMASH) version 5.1.0 [80,81].
For the characteristic of the cluster types predicted to be present in each genome, clusters assigned to
more than one group were pooled in the hybrid group. The strains used in the anti-SMASH analysis
were close relatives of S-2, based on a Blast search, or were strains with high a number of BGCs, as
reported in literature. A tree of 32 high-quality bacterial genomes (Table S4) was generated by retrieving
31 single-copy, housekeeping genes from each genome using AmphoraNet [82]. The sequences of each
individual marker gene were aligned in Geneious Prime software (version 2019.1.1, Geneious, Auckland,
New Zealand) with default parameters and the alignments were concatenated. Poorly aligned positions
were removed utilizing Gblocks software (version 0.91b). A maximum-likelihood phylogenetic tree
was inferred using MEGA 7 software [83]. To support the phylogenetic tree, a bootstrap test with 1000
replicates was performed. Finally, the phylogenetic tree was visualized using the iTOL Interactive tree
of life tool and is available at https://itol.embl.de/tree/1551582516147091575216186#.
4.7. Phenotype Fingerprinting
For phenotype fingerprinting, Streptomyces sp. S-2 was cultured on an MSM-C2 agar plate for
8 days. Next, cells were scraped and suspended in IFIB solution (BiOLOG, Hayward, CA, USA)
until a transmittance of 98% was achieved. The solution was mixed, and a GENIII plate (BiOLOG,
Hayward, CA, USA) was inoculated with 100 µL of cell suspension per well. The absorbance was
measured at λ = 590 nm for each well, and the plate was incubated at 30 ◦C for 48 h. After incubation,
the absorbance of each well was measured again. The readings were corrected for the absorbance of
the negative control by subtracting the value of the A1 well from the rest of the wells. For negative
results, the value was assumed to be zero. Subsequently, readings after 48 h were corrected for
the initial absorbance measured after inoculation. Wells with negative values were assumed to be zero.
The experiment was repeated three times, the values for each well were averaged, and the standard
deviation was calculated.
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4.8. Antifungal Activity Tests
To test antifungal activity, Streptomyces sp. S-2 cultured for 8 days on an MSM-C2 agar plate was
spot-inoculated at three equally distributed spots, 20 mm from the test plate center. Next, an 8 mm
agar puck with mycelia was drilled out of the PDA plates with fungi cultured for 7 days at 22 ◦C
and placed in the center of the test plate (Figure S1). For controls, plates were inoculated in the same
fashion, but were prepared with either S-2 or fungi. For A. niger, F. avenceum, N. oryzae roseF7, and C.
coatesieae junF9, MHA plates were used. For T. citrinoviridae Cin-9, instead of MHA, NA plates were
used, as the growth of this fungi is suppressed on MHA plates. Three control plates for each fungus
and the S-2 were prepared, and at least 15 co-culture plates for each pair were prepared. Plates were
incubated at 25 ◦C, except for T. citrinoviridae Cin-9, which was incubated at 30 ◦C. The plates were
investigated every day for 14 days, and pictures were taken. Antifungal activity was analyzed by
measuring mycelium growth towards the plate border between colonies and towards the S-2 colonies
(Figure S1). Growth distances were measured using Fiji software [74]. A one-way ANOVA test was
carried out to determine the significance of differences in the growth distances, followed by Tukey’s
post hoc test (p ≤ 0.05). Statistical analyses were conducted using Statistica version 13 (Statsoft,
Kraków, Poland). For the second antifungal activity experiment, the plates were prepared in a similar
way, with the exception that inoculated S-2 was precultured for 3, 7, and 14 days before the placement
of an agar puck with mycelia in the center of the plate. The plates were then incubated for 7 days
and classified based on the growth of the mycelia. For each co-culture, the experiment was repeated
three times.
5. Conclusions
We have isolated the Streptomyces sp. S-2 strain from black soot after hard coal combustion collected
from an in-use household chimney. This is the first report of microorganism isolation from black
soot. The isolated strain features strong antifungal activity and inhibits the growth of plant pathogens
and filamentous fungi potentially dangerous to humans. It will be interesting to see if the strain
can protect plants from fungal infections, a study that is currently ongoing. Genome sequencing
and anti-SMASH analysis revealed that although this is not a new species, it contains a very high
number of BGCs present in its genome, a feature that distinguishes it from closely related species.
This indicates the high metabolic potential of S-2 and might increase the strain fitness in harsh
environments e.g. black soot. Many of the detected BGCs show no, or low (below 20%) similarity
to the clusters present in the database, increasing the possibility that S-2 might be a source of novel
compounds for biomedicine and industry. Future, detailed studies on the biosynthetic abilities of
Streptomyces sp. S-2 will elucidate its full biotechnological potential. This work shows that studying
previously neglected and extreme environments might be a source of new strains and compounds,
with a variety of biotechnological implications.
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s1. Figure S1: Schematic representation of the co-culture plate inoculation used for examination of the antifungal
activity of the S-2 strain. The S-2 strain was inoculated at three equally separated points 20 mm from the center of
the plate (green spots), and an agar puck with fungal mycelium was placed at the center of the plate (red spot).
The double arrow lines indicate the measured distance of mycelial growth toward the plate wall (violet line)
and toward the S-2 colony (blue line). For each plate, three sets of measurements were taken. Table S1:
Complete Streptomyces sp. S-2 phenotypic fingerprint based on GEN III microplate assay after 48 h of incubation.
Table S2: Anti-SMASH results for all of the strains used for the BGCs analysis. Table S3: List of strains used in
the phylogenetic analysis, with basic statistics for their genomes and description of isolation sources. Table S4:
List of strains used for the phylogenetic analysis in anti-SMASH analysis with basic statistics for their genomes
and description of isolation sources.
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